| 2.82 -0.12 (-4.08%) | 08-28 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.23 | 1-year : | 5.01 |
| Resists | First : | 3.62 | Second : | 4.28 |
| Pivot price | 2.93 |
|||
| Supports | First : | 2.55 | Second : | 2.12 |
| MAs | MA(5) : | 2.89 |
MA(20) : | 2.93  |
| MA(100) : | 3.82 |
MA(250) : | 7.62 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 9.2 |
D(3) : | 10.4 |
| RSI | RSI(14): 45.5 |
|||
| 52-week | High : | 21.75 | Low : | 2.5 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ VRAX ] has closed above bottom band by 39.5%. Bollinger Bands are 71.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.99 - 3 | 3 - 3.02 |
| Low: | 2.81 - 2.83 | 2.83 - 2.85 |
| Close: | 2.83 - 2.86 | 2.86 - 2.89 |
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The company is developing T cell-based test technologies intended to support an immunology profiling platform, with potential applications in post-acute infection syndromes, including Long COVID, and other chronic conditions linked to immune dysregulation.
Wed, 26 Aug 2026
Virax Biolabs (NASDAQ: VRAX) OKs share surge as charter overhaul fails - Stock Titan
Wed, 19 Aug 2026
VRAX Stock Sees Volatile Moves As Traders Track Support - StocksToTrade
Thu, 09 Jul 2026
Virax Biolabs Shares Double After Exclusive Fosun Distribution Agreement (VRAX) - Yahoo Finance
Thu, 09 Jul 2026
Virax Biolabs Jumps on Fosun Diagnostics Supply Agreement - Quiver Quantitative
Thu, 09 Jul 2026
VRAX Stock Explodes As Traders Chase Wild Momentum - StocksToTrade
Thu, 09 Jul 2026
Why Did Virax Biolabs Stock Triple In One Session? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 529040 (%) |
| Held by Institutions | 2.6 (%) |
| Shares Short | 61 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -6.05e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -35 % |
| Return on Assets (ttm) | 264.9 % |
| Return on Equity (ttm) | -54.3 % |
| Qtrly Rev. Growth | 12420 % |
| Gross Profit (p.s.) | 511.11 |
| Sales Per Share | -58.7 |
| EBITDA (p.s.) | 5738.8 |
| Qtrly Earnings Growth | -12.7 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -5 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.05 |
| Price to Cash Flow | 0.29 |
| Dividend | 0 |
| Forward Dividend | 31480 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|